{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:04:31Z","timestamp":1762560271151,"version":"3.40.5"},"reference-count":162,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014803","name":"European Food Safety Authority","doi-asserted-by":"crossref","award":["GP\/EFSA\/NUTRI\/2014\/01"],"award-info":[{"award-number":["GP\/EFSA\/NUTRI\/2014\/01"]}],"id":[{"id":"10.13039\/100014803","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.numecd.2017.01.008","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T16:33:19Z","timestamp":1487003599000},"page":"473-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924\/2006 in the framework of protection against oxidative damage and cardiovascular health"],"prefix":"10.1016","volume":"27","author":[{"given":"D.","family":"Martini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0346-8410","authenticated-orcid":false,"given":"S.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Biasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Zavaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bedogni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-3922","authenticated-orcid":false,"given":"M.","family":"Musci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-0766","authenticated-orcid":false,"given":"C.","family":"Pruneti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Passeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Di Nuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mirandola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dei Cas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5394-1259","authenticated-orcid":false,"given":"D.","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2017.01.008_bib1","first-page":"3","article-title":"Regulation, EC No 1924\/2006 of the European parliament and of the council of 20 December 2006 on nutrition and health claims made on foods","year":"2007","journal-title":"Off J Eur Union"},{"issue":"Suppl 1","key":"10.1016\/j.numecd.2017.01.008_bib2","article-title":"PASSCLAIM: consensus on criteria","volume":"44","author":"Aggett","year":"2005","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.numecd.2017.01.008_bib3","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2903\/j.efsa.2011.2474","article-title":"Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health","volume":"9","author":"EFSA NDA Panel (EFSA Panel on Dietetic Products Nutrition and Allergies)","year":"2011","journal-title":"EFSA J"},{"key":"10.1016\/j.numecd.2017.01.008_bib4","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.2903\/j.efsa.2012.2604","article-title":"Guidance on the scientific requirements for health claims related to appetite ratings, weight management, and blood glucose concentrations","volume":"10","author":"EFSA NDA Panel (EFSA Panel on Dietetic Products Nutrition and Allergies)","year":"2012","journal-title":"EFSA J"},{"key":"10.1016\/j.numecd.2017.01.008_bib5","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.2903\/j.efsa.2012.2702","article-title":"Guidance on the scientific requirements for health claims related to bone, joints, skin, and oral health","volume":"10","author":"EFSA NDA Panel (EFSA Panel on Dietetic Products Nutrition and Allergies)","year":"2012","journal-title":"EFSA J"},{"key":"10.1016\/j.numecd.2017.01.008_bib6","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.2903\/j.efsa.2012.2816","article-title":"Guidance on the scientific requirements for health claims related to functions of the nervous system, including psychological functions","volume":"10","author":"EFSA NDA Panel (EFSA Panel on Dietetic Products Nutrition and Allergies)","year":"2012","journal-title":"EFSA J"},{"key":"10.1016\/j.numecd.2017.01.008_bib7","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.2903\/j.efsa.2016.4369","article-title":"Guidance on the scientific requirements for health claims related to the immune system, the gastrointestinal tract and defence against pathogenic microorganisms","volume":"14","author":"EFSA NDA Panel (EFSA Panel on Dietetic Products Nutrition and Allergies)","year":"2016","journal-title":"EFSA J"},{"key":"10.1016\/j.numecd.2017.01.008_bib8","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.2903\/j.efsa.2012.2817","article-title":"Guidance on the scientific requirements for health claims related to physical performance","volume":"10","author":"EFSA NDA Panel (EFSA Panel on Dietetic Products Nutrition and Allergies)","year":"2012","journal-title":"EFSA J"},{"key":"10.1016\/j.numecd.2017.01.008_bib9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0278-6915(99)00090-3","article-title":"Intracellular antioxidants: from chemical to biochemical mechanisms","volume":"37","author":"Chaudiere","year":"1999","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.numecd.2017.01.008_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nprot.2009.197","article-title":"Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue","volume":"5","author":"Weydert","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.numecd.2017.01.008_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.107.07104","article-title":"Pharmacological and clinical aspects of heme oxygenase","volume":"60","author":"Abraham","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.numecd.2017.01.008_bib12","first-page":"369","article-title":"Heme oxygenase activity. Current methods and applications","volume":"99","author":"Ryter","year":"2000","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.numecd.2017.01.008_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1570-0232(02)00618-9","article-title":"Analytical methods to investigate glutathione and related compounds in biological and pathological processes","volume":"781","author":"Camera","year":"2002","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.numecd.2017.01.008_bib14","first-page":"172","article-title":"Recent advances in analysis of glutathione in biological samples by high-performance liquid chromatography: a brief overview","volume":"7","author":"Santa","year":"2013","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.numecd.2017.01.008_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/mutage\/get001","article-title":"An ECVAG inter-laboratory validation study of the Comet Assay: inter-laboratory and intra-laboratory variations of DNA strand breaks and FPG-sensitive sites in human mononuclear cells","volume":"28","author":"Ersson","year":"2013","journal-title":"Mutagenesis"},{"key":"10.1016\/j.numecd.2017.01.008_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/10590500902885684","article-title":"8-hydroxy-2' -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"key":"10.1016\/j.numecd.2017.01.008_bib17","first-page":"333","article-title":"ESCODD (European standards committee on oxidative DNA damage)","volume":"32","author":"Comparison of different methods of measuring 8-oxoguanine as a marker of oxidative DNA damage","year":"2000","journal-title":"Free Radic Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1089\/ars.2009.2597","article-title":"Generation and biological activities of oxidized phospholipids","volume":"12","author":"Bochkov","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.numecd.2017.01.008_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","article-title":"Biomarkers of oxidative damage in human disease","volume":"52","author":"Dalle-Donne","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2017.01.008_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/01.ATV.0000152605.64964.c0","article-title":"Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans","volume":"25","author":"Morrow","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2017.01.008_bib21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3109\/10715762.2010.499907","article-title":"An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples","volume":"44","author":"Breusing","year":"2010","journal-title":"Free Radic Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/rcm.4871","article-title":"Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography\/tandem mass spectrometry cannot be compared","volume":"25","author":"Klawitter","year":"2011","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.numecd.2017.01.008_bib23","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/ATVBAHA.108.179697","article-title":"Oxidized low-density lipoprotein and atherosclerosis","volume":"30","author":"Steinberg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2017.01.008_bib24","doi-asserted-by":"crossref","first-page":"714653","DOI":"10.1155\/2013\/714653","article-title":"The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts","volume":"2013","author":"Maiolino","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.numecd.2017.01.008_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.14.1","article-title":"Measurement of plasma oxidized low-density lipoprotein and its clinical implications","volume":"14","author":"Itabe","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.numecd.2017.01.008_bib26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/clinchem\/46.6.822","article-title":"Age-related increases in plasma phosphatidylcholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia","volume":"46","author":"Kinoshita","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2017.01.008_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jchromb.2007.06.019","article-title":"An improved HPLC assay for phosphatidylcholine hydroperoxides (PCOOH) in human plasma with synthetic PCOOH as internal standard","volume":"857","author":"Hui","year":"2007","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.numecd.2017.01.008_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2017.01.008_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2007.01.028","article-title":"Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking","volume":"380","author":"Lykkesfeldt","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.numecd.2017.01.008_bib30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1194\/jlr.D032698","article-title":"A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC","volume":"54","author":"Moselhy","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1081\/DMR-100102336","article-title":"Quantification and significance of protein oxidation in biological samples","volume":"32","author":"Shacter","year":"2000","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.numecd.2017.01.008_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00726-011-1175-9","article-title":"Modulating protein activity and cellular function by methionine residue oxidation","volume":"43","author":"Cui","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.numecd.2017.01.008_bib33","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0891-5849(02)00792-X","article-title":"Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress","volume":"32","author":"Heinecke","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.freeradbiomed.2009.01.007","article-title":"Quantification of protein modification by oxidants","volume":"46","author":"Hawkins","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-8981(03)00003-2","article-title":"Protein carbonyl groups as biomarkers of oxidative stress","volume":"329","author":"Dalle-Donne","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.numecd.2017.01.008_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.redox.2015.06.005","article-title":"Determination of protein carbonyls in plasma, cell extracts, tissue homogenates, isolated proteins: focus on sample preparation and derivatization conditions","volume":"5","author":"Weber","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.numecd.2017.01.008_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jssc.200600314","article-title":"Chromatographic and electrophoretic methods for the analysis of biomarkers of oxidative damage to macromolecules (DNA, lipids, and proteins)","volume":"30","author":"Mateos","year":"2007","journal-title":"J Sep Sci"},{"key":"10.1016\/j.numecd.2017.01.008_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0891-5849(97)00104-4","article-title":"Protein carbonyl measurement by a sensitive ELISA method","volume":"23","author":"Buss","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1357-2725(99)00034-5","article-title":"Quantitation of oxidative damage to tissue proteins","volume":"31","author":"Fagan","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.numecd.2017.01.008_bib40","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.freeradbiomed.2006.08.013","article-title":"Mass spectrometry of protein modifications by reactive oxygen and nitrogen species","volume":"41","author":"Schoneich","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2014.05.015","article-title":"Review of clinical practice guidelines for the management of LDL-related risk","volume":"64","author":"Morris","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.beem.2013.10.010","article-title":"Is lower better and is it safe?","volume":"28","author":"Stein","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2017.01.008_bib43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/eurheartj\/ehu107","article-title":"The ACC\/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC\/EAS guidelines for the management of dyslipidaemias 2011","volume":"35","author":"Ray","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2017.01.008_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00508-014-0513-9","article-title":"New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk","volume":"126","author":"Klose","year":"2014","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.numecd.2017.01.008_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7326\/M14-0126","article-title":"Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology\/American Heart Association cholesterol guideline","volume":"160","author":"Stone","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jama.2013.284203","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol: a fresh interpretation of old evidence","volume":"311","author":"Psaty","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2017.01.008_bib47","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/STROKEAHA.113.001326","article-title":"Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis","volume":"44","author":"Wang","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.numecd.2017.01.008_bib48","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European society of Cardiology (ESC) and the European atherosclerosis society (EAS)","volume":"32","author":"European Association for Cardiovascular P","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2017.01.008_bib49","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib50","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Cholesterol Treatment Trialists C","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2017.01.008_bib51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.numecd.2014.04.002","article-title":"Merits and potential downsides of the 2013 ACC\/AHA cholesterol management guidelines","volume":"24","author":"Gotto","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2017.01.008_bib52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2261-14-60","article-title":"Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound","volume":"14","author":"Gao","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.numecd.2017.01.008_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3810\/pgm.2014.11.2831","article-title":"The new cholesterol treatment guidelines from the American College of Cardiology\/American Heart Association, 2013: what clinicians need to know","volume":"126","author":"Lim","year":"2014","journal-title":"Postgrad Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib54","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.clinbiochem.2004.03.008","article-title":"Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population","volume":"37","author":"Tremblay","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.numecd.2017.01.008_bib55","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1373\/clinchem.2014.227710","article-title":"Validation of a proposed novel equation for estimating LDL cholesterol","volume":"60","author":"Meeusen","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2017.01.008_bib56","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2017.01.008_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.atherosclerosis.2013.10.011","article-title":"HDL-C, triglycerides and carotid IMT: a meta-analysis of 21,000 patients with automated edge detection IMT measurement","volume":"232","author":"Touboul","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2017.01.008_bib58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(00)00603-1","article-title":"HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study","volume":"153","author":"Despres","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2017.01.008_bib59","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1161\/01.CIR.0000154555.07002.CA","article-title":"Cardiology patient page. The \u201cgood cholesterol\u201d: high-density lipoprotein","volume":"111","author":"Toth","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2017.01.008_bib60","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1093\/eurheartj\/eht343","article-title":"High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality","volume":"34","author":"Silbernagel","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2017.01.008_bib61","doi-asserted-by":"crossref","first-page":"e94585","DOI":"10.1371\/journal.pone.0094585","article-title":"Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression","volume":"9","author":"Kaur","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2017.01.008_bib62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2013.12.033","article-title":"Validation of homogeneous assays for HDL-cholesterol using fresh samples from healthy and diseased subjects","volume":"233","author":"Miida","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2017.01.008_bib63","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2017.01.008_bib64","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/clinchem\/19.5.476","article-title":"Quantitative determination of serum triglycerides by the use of enzymes","volume":"19","author":"Bucolo","year":"1973","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2017.01.008_bib65","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbalip.2012.01.006","article-title":"Postprandial metabolism of meal triglyceride in humans","volume":"1821","author":"Lambert","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.numecd.2017.01.008_bib66","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1055\/s-2001-15116","article-title":"Postprandial triglycerides and endothelial function","volume":"109","author":"Jagla","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.numecd.2017.01.008_bib67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157016111795495530","article-title":"Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis","volume":"9","author":"Mihas","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.numecd.2017.01.008_bib68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/157016111795495585","article-title":"Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol","volume":"9","author":"Nordestgaard","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.numecd.2017.01.008_bib69","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cjca.2013.01.005","article-title":"The 2013 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"29","author":"Hackam","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-138-1-200301070-00006","article-title":"Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study","volume":"138","author":"Haider","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib71","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2017.01.008_bib72","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2017.01.008_bib73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.jhh.1001373","article-title":"Systolic vs diastolic blood pressure and the burden of hypertension","volume":"16","author":"Tin","year":"2002","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.numecd.2017.01.008_bib74","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.289.8.1027","article-title":"Measuring blood pressure accurately: new and persistent challenges","volume":"289","author":"Jones","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2017.01.008_bib75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.jhh.1001310","article-title":"Systolic vs diastolic blood pressure: community burden and impact on blood pressure staging","volume":"16","author":"Banegas","year":"2002","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.numecd.2017.01.008_bib76","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.amjmed.2009.05.020","article-title":"Discrepancies between office and ambulatory blood pressure: clinical implications","volume":"122","author":"Banegas","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib77","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1291\/hypres.27.755","article-title":"Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: first Report of the Japan home versus office blood pressure measurement evaluation (J-HOME) study","volume":"27","author":"Ohkubo","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib78","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.HYP.0000229661.06235.08","article-title":"Recommendations for blood pressure measurement in human and experimental animals; part 1: blood pressure measurement in humans","volume":"48","author":"Atherosclerosis H","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2017.01.008_bib79","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/HYPERTENSIONAHA.114.05038","article-title":"Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement","volume":"65","author":"Zhang","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2017.01.008_bib80","doi-asserted-by":"crossref","first-page":"e1001591","DOI":"10.1371\/journal.pmed.1001591","article-title":"Risk stratification by self-measured home blood pressure across categories of conventional blood pressure: a participant-level meta-analysis","volume":"11","author":"Asayama","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib81","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jacc.2005.05.058","article-title":"Home blood pressure measurement: a systematic review","volume":"46","author":"Verberk","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/1440-1681.12149","article-title":"Replacing manual sphygmomanometers with automated blood pressure measurement in routine clinical practice","volume":"41","author":"Myers","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib83","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.HYP.32.2.255","article-title":"Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study","volume":"32","author":"Ohkubo","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2017.01.008_bib84","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","article-title":"European Society of Hypertension position paper on ambulatory blood pressure monitoring","volume":"31","author":"O'Brien","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2017.01.008_bib85","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.108.122853","article-title":"Why is out-of-office blood pressure measurement needed?","volume":"54","author":"Parati","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2017.01.008_bib86","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/HYPERTENSIONAHA.114.03839","article-title":"Thresholds for conventional and home blood pressure by sex and age in 5018 participants from 5 populations","volume":"64","author":"Nomura","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2017.01.008_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.mbp.0000180669.38161.6e","article-title":"Is the area under blood pressure curve the best parameter to evaluate 24-h ambulatory blood pressure monitoring data?","volume":"10","author":"Nobre","year":"2005","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.numecd.2017.01.008_bib88","doi-asserted-by":"crossref","first-page":"H2380","DOI":"10.1152\/ajpheart.00902.2008","article-title":"Racial differences in central blood pressure and vascular function in young men","volume":"295","author":"Heffernan","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib89","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/HYPERTENSIONAHA.106.083592","article-title":"Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes","volume":"49","author":"Mosley","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2017.01.008_bib90","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1002\/sim.1921","article-title":"Using the area under the curve to reduce measurement error in predicting young adult blood pressure from childhood measures","volume":"23","author":"Cook","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib91","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2261-12-48","article-title":"Assessment of central haemomodynamics from a brachial cuff in a community setting","volume":"12","author":"Nunan","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.numecd.2017.01.008_bib92","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/HJH.0b013e3283633589","article-title":"A review of methods to determine the functional arterial parameters stiffness and resistance","volume":"31","author":"Westerhof","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2017.01.008_bib93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11906-012-0325-0","article-title":"Treatment of arterial remodeling in essential hypertension","volume":"15","author":"Briet","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.numecd.2017.01.008_bib94","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/ATVBAHA.114.304798","article-title":"Effect of weight loss on pulse wave velocity: systematic review and meta-analysis","volume":"35","author":"Petersen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2017.01.008_bib95","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijcard.2014.03.072","article-title":"The impact of aerobic exercise training on arterial stiffness in pre- and hypertensive subjects: a systematic review and meta-analysis","volume":"173","author":"Montero","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib96","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2012.03.039","article-title":"Ambulatory arterial stiffness index: a systematic review and meta-analysis","volume":"224","author":"Kollias","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2017.01.008_bib97","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11906-012-0272-9","article-title":"Pulse pressure, arterial stiffness, and end-organ damage","volume":"14","author":"Safar","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.numecd.2017.01.008_bib98","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYP.0000000000000033","article-title":"Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American heart association","volume":"66","author":"Townsend","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2017.01.008_bib99","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/MNH.0b013e32835856e3","article-title":"Methods for assessing arterial stiffness: technical considerations","volume":"21","author":"Tomlinson","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.numecd.2017.01.008_bib100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/HYPERTENSIONAHA.113.02044","article-title":"Is flow-mediated dilation nitric oxide mediated?: A meta-analysis","volume":"63","author":"Green","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2017.01.008_bib101","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1475-097X.2004.00575.x","article-title":"Non-invasive assessment of endothelial function - relation between vasodilatory responses in skin microcirculation and brachial artery","volume":"24","author":"Hansell","year":"2004","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.numecd.2017.01.008_bib102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1536\/ihj.14-385","article-title":"Assessment of endothelial function. History, methodological aspects, and clinical perspectives","volume":"56","author":"Higashi","year":"2015","journal-title":"Int Heart J"},{"key":"10.1016\/j.numecd.2017.01.008_bib103","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines","volume":"56","author":"Greenland","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib104","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/eurheartj\/ehi017","article-title":"Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response","volume":"26","author":"Bots","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2017.01.008_bib105","doi-asserted-by":"crossref","first-page":"H2","DOI":"10.1152\/ajpheart.00471.2010","article-title":"Assessment of flow-mediated dilation in humans: a methodological and physiological guideline","volume":"300","author":"Thijssen","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib106","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.109.864801","article-title":"Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis","volume":"120","author":"Yeboah","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2017.01.008_bib107","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.hco.0000126581.89648.10","article-title":"Arterial stiffness and the systolic hypertension syndrome","volume":"19","author":"Izzo","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib108","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/HJH.0b013e32834e4b0f","article-title":"The association between preeclampsia and arterial stiffness","volume":"30","author":"Hausvater","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2017.01.008_bib109","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MNH.0b013e3283499d7b","article-title":"Vascular compliance in blood pressure","volume":"20","author":"Raij","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.numecd.2017.01.008_bib110","first-page":"H1540","article-title":"Evaluation of methods for estimation of total arterial compliance","volume":"268","author":"Stergiopulos","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib111","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12265-012-9359-6","article-title":"Arterial stiffness: basic concepts and measurement techniques","volume":"5","author":"Chirinos","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib112","doi-asserted-by":"crossref","first-page":"11477","DOI":"10.1073\/pnas.0402201101","article-title":"Biological activity of nitric oxide in the plasmatic compartment","volume":"101","author":"Wang","year":"2004","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.numecd.2017.01.008_bib113","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0891-5849(02)01183-8","article-title":"Concomitant presence of N-nitroso and S-nitroso proteins in human plasma","volume":"33","author":"Rassaf","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.numecd.2017.01.008_bib114","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0076-6879(08)01216-0","article-title":"Reductive gas-phase chemiluminescence and flow injection analysis for measurement of the nitric oxide pool in biological matrices","volume":"441","author":"Hendgen-Cotta","year":"2008","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.numecd.2017.01.008_bib115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0268-960X(95)90020-9","article-title":"Platelet activation","volume":"9","author":"Blockmans","year":"1995","journal-title":"Blood Rev"},{"key":"10.1016\/j.numecd.2017.01.008_bib116","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1309\/Y9EC63RW3XG1V313","article-title":"Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field","volume":"123","author":"Zhou","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.numecd.2017.01.008_bib117","first-page":"50","article-title":"Platelet aggregation in whole blood, a new approach for understanding the antiplatelet effect of N-(3-hydroxy-1,3,5(10)-estratrien-17b-yl) butylamine (buame)","volume":"52","author":"de la Pena","year":"2009","journal-title":"Proc West Pharmacol Soc"},{"key":"10.1016\/j.numecd.2017.01.008_bib118","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1538-7836.2008.02891.x","article-title":"Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary","volume":"6","author":"Linnemann","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.numecd.2017.01.008_bib119","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.thromres.2006.11.012","article-title":"Measuring antiplatelet drug effects in the laboratory","volume":"120","author":"Harrison","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib120","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2174\/138161206776055921","article-title":"From the design to the clinical application of thromboxane modulators","volume":"12","author":"Dogne","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.numecd.2017.01.008_bib121","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"Thromboxane A2: physiology\/pathophysiology, cellular signal transduction and pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.numecd.2017.01.008_bib122","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thromres.2007.12.011","article-title":"Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production","volume":"122","author":"Riondino","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib123","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2013.10.030","article-title":"Soluble P-selectin: the next step","volume":"133","author":"Blann","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib124","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11239-011-0590-9","article-title":"Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data","volume":"32","author":"Sharma","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.numecd.2017.01.008_bib125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000044903","article-title":"Soluble P-selectin is released from activated platelets in\u00a0vivo during hemodialysis","volume":"78","author":"Kawabata","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.numecd.2017.01.008_bib126","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","article-title":"The P-selectin, tissue factor, coagulation triad","volume":"3","author":"Polgar","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.numecd.2017.01.008_bib127","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/ejh.12262","article-title":"An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients","volume":"92","author":"Vinholt","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.numecd.2017.01.008_bib128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1258\/000456303763046094","article-title":"Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: comparison with the plasma Abbott IMx method","volume":"40","author":"McCann","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.numecd.2017.01.008_bib129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2014.05.023","article-title":"Quantification of folate metabolites in serum using ultraperformance liquid chromatography tandem mass spectrometry","volume":"962","author":"Wang","year":"2014","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.numecd.2017.01.008_bib130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jvs.2011.06.121","article-title":"Multicenter assessment of venous reflux by duplex ultrasound","volume":"55","author":"Lurie","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.numecd.2017.01.008_bib131","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jsurg.2015.02.004","article-title":"Validation of a novel venous duplex ultrasound objective structured assessment of technical skills for the assessment of venous reflux","volume":"72","author":"Jaffer","year":"2015","journal-title":"J Surg Educ"},{"key":"10.1016\/j.numecd.2017.01.008_bib132","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejvs.2005.07.020","article-title":"Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs\u2013UIP consensus document. Part II. Anatomy","volume":"31","author":"Cavezzi","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.numecd.2017.01.008_bib133","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejvs.2005.07.019","article-title":"Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs\u2013UIP consensus document. Part I. Basic principles","volume":"31","author":"Coleridge-Smith","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.numecd.2017.01.008_bib134","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2011.01.079","article-title":"The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum","volume":"53","author":"Gloviczki","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.numecd.2017.01.008_bib135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000060613","article-title":"Venous mapping with Doppler and duplex sonography","volume":"27","author":"Rabe","year":"1999","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.numecd.2017.01.008_bib136","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejvs.2012.10.014","article-title":"Great saphenous vein diameter at the saphenofemoral junction and proximal thigh as parameters of venous disease class","volume":"45","author":"Mendoza","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.numecd.2017.01.008_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.avsg.2011.02.045","article-title":"Popliteal vein aneurysm as a source of pulmonary embolism: report of a case and review of the world literature","volume":"25","author":"Park","year":"2011","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.numecd.2017.01.008_bib138","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0741-5214(99)70247-8","article-title":"Lower limb deep venous flow in patients with peripheral vascular disease","volume":"29","author":"Libertiny","year":"1999","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.numecd.2017.01.008_bib139","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1024\/0301-1526\/a000301","article-title":"Popliteal vein compression with the limb extended","volume":"42","author":"Spacil","year":"2013","journal-title":"VASA"},{"key":"10.1016\/j.numecd.2017.01.008_bib140","first-page":"355","article-title":"Niemann-pick C1-Like 1 protein: another target for treatment of dyslipidemia? Evidence from the myocardial infarction genetic consortium and IMPROVE-IT trials","volume":"2014","author":"Hassan","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.numecd.2017.01.008_bib141","doi-asserted-by":"crossref","first-page":"g4379","DOI":"10.1136\/bmj.g4379","article-title":"Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients","volume":"349","author":"Keene","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2017.01.008_bib142","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00228-009-0720-x","article-title":"Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study","volume":"65","author":"Sheng","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.numecd.2017.01.008_bib143","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/clinchem\/48.5.737","article-title":"Highly sensitive cholesterol assay with enzymatic cycling applied to measurement of remnant lipoprotein-cholesterol in serum","volume":"48","author":"Kishi","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2017.01.008_bib144","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clinbiochem.2012.11.026","article-title":"Validation of a reference method for total cholesterol measurement in human serum and assignation of reference values to proficiency testing samples","volume":"46","author":"Heuillet","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.numecd.2017.01.008_bib145","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2147\/VHRM.S52713","article-title":"Association between triglycerides and cardiovascular events in primary populations: a meta-regression analysis and synthesis of evidence","volume":"9","author":"Stauffer","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.numecd.2017.01.008_bib146","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2013.03.011","article-title":"Triglyceride-rich lipoproteins and HDL: what do recent trials tell us?","volume":"228","author":"Stock","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2017.01.008_bib147","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10654-007-9165-7","article-title":"The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases","volume":"22","author":"Emerging Risk Factors C","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib148","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11883-008-0060-9","article-title":"Triglycerides and risk for coronary artery disease","volume":"10","author":"McBride","year":"2008","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.numecd.2017.01.008_bib149","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12170-010-0131-7","article-title":"Clinical implications of lipid genetics for cardiovascular disease","volume":"4","author":"Strong","year":"2010","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.numecd.2017.01.008_bib150","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1017\/S000711451200520X","article-title":"Plasma total homocysteine status of vegetarians compared with omnivores: a systematic review and meta-analysis","volume":"109","author":"Obersby","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1016\/j.numecd.2017.01.008_bib151","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ramb.2013.05.004","article-title":"Homocysteine: cardiovascular risk factor in children and adolescents?","volume":"59","author":"Leal","year":"2013","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.numecd.2017.01.008_bib152","first-page":"183","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi","year":"2005","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.numecd.2017.01.008_bib153","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2013.04.010","article-title":"Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study","volume":"74","author":"Karolczak","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib154","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1076029607308390","article-title":"Homocysteine activates platelets in\u00a0vitro","volume":"14","author":"Mohan","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.numecd.2017.01.008_bib155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11906-013-0401-0","article-title":"Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses","volume":"15","author":"Gaciong","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.numecd.2017.01.008_bib156","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.artres.2009.02.002","article-title":"Arterial stiffness and wave reflection: biomarkers of cardiovascular risk","volume":"3","author":"Mitchell","year":"2009","journal-title":"Artery Res"},{"key":"10.1016\/j.numecd.2017.01.008_bib157","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.diii.2013.01.025","article-title":"Arterial wall elasticity: state of the art and future prospects","volume":"94","author":"Messas","year":"2013","journal-title":"Diagn Interv Imaging"},{"issue":"Suppl B","key":"10.1016\/j.numecd.2017.01.008_bib158","doi-asserted-by":"crossref","first-page":"72B","DOI":"10.1016\/S0828-282X(06)70990-4","article-title":"Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk","volume":"22","author":"Anderson","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.numecd.2017.01.008_bib159","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/cpf.12093","article-title":"The effects of exercise training on arterial stiffness in coronary artery disease patients: a state-of-the-art review","volume":"34","author":"Oliveira","year":"2014","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.numecd.2017.01.008_bib160","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.2903\/j.efsa.2014.3890","article-title":"Scientific Opinion on the substantiation of a health claim related to selenium and protection of DNA, proteins and lipids from oxidative damage pursuant to Article 14 of Regulation (EC) No 1924\/2006","volume":"12","author":"EFSA Panel on Dietetic Products","year":"2014","journal-title":"EFSA J"},{"key":"10.1016\/j.numecd.2017.01.008_bib161","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2903\/j.efsa.2009.1220","volume":"7","author":"EFSA Panel on Dietetic Products","year":"2009","journal-title":"EFSA J"},{"key":"10.1016\/j.numecd.2017.01.008_bib162","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2903\/j.efsa.2010.1727","volume":"8","author":"EFSA Panel on Dietetic Products","year":"2010","journal-title":"EFSA J"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475317300236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475317300236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T09:47:39Z","timestamp":1601632059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475317300236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":162,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0939475317300236"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2017.01.008","relation":{},"ISSN":["0939-4753"],"issn-type":[{"type":"print","value":"0939-4753"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924\/2006 in the framework of protection against oxidative damage and cardiovascular health","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2017.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}